Ameriprise Financial Inc Pfizer Inc Transaction History

Ameriprise Financial Inc

$358 Billion
Q1 2024

A detailed history of Ameriprise Financial Inc transactions in Pfizer Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 18,540,204 shares of PFE stock, worth $519 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

18,540,204

Previous 20,729,412 10.56%

Holding current value

$519 Million

Previous $597 Million 13.79%

% of portfolio

0.14%

Previous 0.18%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $56.7 Million - $65.1 Million	-2,189,208 Reduced 10.56%	18,540,204 $514 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $215 Million - $279 Million	8,223,229 Added 65.75%	20,729,412 $597 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $321 Million - $375 Million	-9,998,619 Reduced 44.43%	12,506,183 $415 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $30.9 Million - $35.7 Million	-855,359 Reduced 3.66%	22,504,802 $825 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $34 Million - $44.3 Million	863,374 Added 3.84%	23,360,161 $953 Million

Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $10.9 Million - $14.3 Million	262,117 Added 1.18%	22,496,787 $1.15 Billion
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $7.92 Million - $9.67 Million	180,952 Added 0.82%	22,234,670 $973 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $26.1 Million - $30.9 Million	-560,926 Reduced 2.48%	22,053,718 $1.16 Billion
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $200 Million - $247 Million	4,361,710 Added 23.9%	22,614,644 $1.17 Billion
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $16.7 Million - $24.8 Million	-404,892 Reduced 2.17%	18,252,934 $1.07 Billion
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $44.3 Million - $56.9 Million	1,129,497 Added 6.44%	18,657,826 $802 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $14.8 Million - $16.8 Million	-412,007 Reduced 2.3%	17,528,329 $687 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $317 Million - $357 Million	9,451,863 Added 111.35%	17,940,336 $650 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $293 Million - $373 Million	-8,765,378 Reduced 50.8%	8,488,473 $313 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $34.5 Million - $40.5 Million	-1,086,011 Reduced 5.92%	17,253,851 $633 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $51.7 Million - $62.7 Million	-1,715,171 Reduced 8.55%	18,339,862 $599 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $114 Million - $162 Million	-4,204,167 Reduced 17.33%	20,055,033 $655 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $20.6 Million - $23.4 Million	-626,413 Reduced 2.52%	24,259,200 $951 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $327 Million - $424 Million	-10,069,352 Reduced 28.81%	24,885,613 $894 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $24.8 Million - $27.8 Million	670,555 Added 1.96%	34,954,965 $1.51 Billion
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $393 Million - $432 Million	-10,474,871 Reduced 23.4%	34,284,410 $1.46 Billion
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $313 Million - $357 Million	-8,134,727 Reduced 15.38%	44,759,281 $1.95 Billion
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $76.4 Million - $92.7 Million	-2,217,128 Reduced 4.02%	52,894,008 $2.41 Billion
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $9.06 Million - $9.65 Million	274,595 Added 0.5%	55,111,136 $2 Billion
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $175 Million - $203 Million	-5,475,872 Reduced 9.08%	54,836,541 $1.95 Billion
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $15.6 Million - $16.5 Million	468,389 Added 0.78%	60,312,413 $2.18 Billion
Q3 2017 Nov 07, 2017	BUY	$31.0 - $34.15 $1.86 Billion - $2.04 Billion	59,844,024	59,844,024 $2.14 Billion

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Pfizer Inc Transaction History